Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

When I arrived in Minneapolis, the frost had just lifted, and gray clouds hung low over the horizon. I had come to make a pilgrimage to George Floyd Square, where the revolution of 2020 began. It has ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

During the summer of 2020, when protests convulsed cities around the world, one of the most striking scenes took place outside a library in a wealthy Maryland suburb. Eight days after George Floyd was ...

Kirk made the statement in reference to Floyd's alleged criminal history and the circumstances surrounding his death. Kirk's exact words were: "I am also going to offer some context and some nuance ...

The boxing world was hit with a big announcement on Thursday night when former heavyweight champion Mike Tyson and former multi-division champion Floyd Mayweather said they agreed to a bout to be held ...

June 10 (Reuters) - Recursion Pharmaceuticals (RXRX.O), opens new tab said on Tuesday it would lay off about 20% of its workforce as the biotech company tries to cope with an industry-wide funding ...

Shares of Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict ...

Five years ago, the fight for racial justice reached a fever pitch when George Floyd was killed by a White police officer, Derek Chauvin. The world watched in horror as Chauvin placed his knee on ...